BR112014009643A2 - métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal - Google Patents
métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretalInfo
- Publication number
- BR112014009643A2 BR112014009643A2 BR112014009643A BR112014009643A BR112014009643A2 BR 112014009643 A2 BR112014009643 A2 BR 112014009643A2 BR 112014009643 A BR112014009643 A BR 112014009643A BR 112014009643 A BR112014009643 A BR 112014009643A BR 112014009643 A2 BR112014009643 A2 BR 112014009643A2
- Authority
- BR
- Brazil
- Prior art keywords
- colorectal neoplasia
- biomarker
- diagnosing
- kits
- diagnosis
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 2
- 230000009826 neoplastic cell growth Effects 0.000 title 2
- 206010061818 Disease progression Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 230000005750 disease progression Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122015004941-5A BR122015004941B1 (pt) | 2011-10-21 | 2012-10-20 | Método para detectar adenomas colorretais avançados em um sujeito humano |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161550148P | 2011-10-21 | 2011-10-21 | |
US61/550,148 | 2011-10-21 | ||
PCT/IB2012/003035 WO2013093635A2 (en) | 2011-10-21 | 2012-10-20 | Plasma micrornas for the detection of early colorectal cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014009643A2 true BR112014009643A2 (pt) | 2017-12-12 |
BR112014009643B1 BR112014009643B1 (pt) | 2020-12-15 |
Family
ID=48136439
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014009643-0A BR112014009643B1 (pt) | 2011-10-21 | 2012-10-20 | Método para diagnosticar ou detectar neoplasia colorretal |
BR122015004941-5A BR122015004941B1 (pt) | 2011-10-21 | 2012-10-20 | Método para detectar adenomas colorretais avançados em um sujeito humano |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122015004941-5A BR122015004941B1 (pt) | 2011-10-21 | 2012-10-20 | Método para detectar adenomas colorretais avançados em um sujeito humano |
Country Status (18)
Country | Link |
---|---|
US (6) | US20130102487A1 (pt) |
EP (2) | EP2768986B1 (pt) |
JP (2) | JP6159727B2 (pt) |
KR (2) | KR101912731B1 (pt) |
CN (2) | CN104145024A (pt) |
AU (1) | AU2012356317B2 (pt) |
BR (2) | BR112014009643B1 (pt) |
CA (1) | CA2852850C (pt) |
DK (2) | DK2768986T3 (pt) |
ES (2) | ES2688693T3 (pt) |
HU (2) | HUE035614T2 (pt) |
IN (1) | IN2015DN01855A (pt) |
MX (2) | MX357119B (pt) |
NO (1) | NO3051026T3 (pt) |
PL (2) | PL2768986T3 (pt) |
PT (2) | PT2768986T (pt) |
RU (2) | RU2662975C1 (pt) |
WO (1) | WO2013093635A2 (pt) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014513521A (ja) | 2011-01-26 | 2014-06-05 | セファイド | 肺癌を検出する方法 |
US10876152B2 (en) | 2012-09-04 | 2020-12-29 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
IL305303A (en) | 2012-09-04 | 2023-10-01 | Guardant Health Inc | Systems and methods for detecting rare mutations and changes in number of copies |
US11913065B2 (en) | 2012-09-04 | 2024-02-27 | Guardent Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
JP6571665B2 (ja) | 2013-12-28 | 2019-09-04 | ガーダント ヘルス, インコーポレイテッド | 遺伝的バリアントを検出するための方法およびシステム |
EP3108012A4 (en) | 2014-02-18 | 2017-10-11 | Baylor Research Institute | Mir-320e and colorectal cancer |
EP3971299A3 (en) * | 2014-06-13 | 2022-06-29 | Toray Industries, Inc. | Colorectal cancer detection kit or device, and detection method |
WO2016034715A2 (fr) * | 2014-09-05 | 2016-03-10 | Prestizia | Methode de prediction de l'evolution clinique du cancer colorectal |
CN104313142B (zh) * | 2014-10-16 | 2016-02-03 | 上海交通大学医学院附属仁济医院 | miRNA-30a作为标记分子在制备诊断试剂中的用途 |
CN104388541B (zh) * | 2014-10-21 | 2017-07-04 | 复旦大学附属肿瘤医院 | miR‑1914*和miR‑1915的用途 |
CN104372004B (zh) * | 2014-12-04 | 2018-04-27 | 广东医学院 | 一个与心肌梗死易感相关的miR-27a基因单核苷酸多态位点的检测方法及其应用 |
EP3147370A1 (en) | 2015-09-28 | 2017-03-29 | Rheinische Friedrich-Wilhelms-Universität Bonn | Exosomal microrna in serum as an indicator for the activation of brown and beige fat tissue (bat) |
CN108603228B (zh) | 2015-12-17 | 2023-09-01 | 夸登特健康公司 | 通过分析无细胞dna确定肿瘤基因拷贝数的方法 |
CN110139936A (zh) * | 2016-08-18 | 2019-08-16 | N·特兰 | 口腔癌、咽癌和喉癌的生物标记 |
EP3327135A1 (en) * | 2016-11-28 | 2018-05-30 | Advanced Marker Discovery, S.L. | In vitro method for identifying colorectal adenomas or colorectal cancer |
CN106950370A (zh) * | 2017-01-25 | 2017-07-14 | 上海市第十人民医院 | 血液微小核酸大肠癌诊断分子组合 |
CN107254522A (zh) * | 2017-06-09 | 2017-10-17 | 中山大学附属第三医院 | miR‑664a‑5p的检测试剂在制备肝癌诊断试剂/试剂盒中的应用 |
CN107236799B (zh) * | 2017-06-15 | 2020-06-09 | 昆明医科大学第六附属医院 | 一种肾纤维化miRNA标记物 |
CN107326092B (zh) * | 2017-08-25 | 2021-07-20 | 深圳市恩普电子技术有限公司 | 大肠癌相关的miRNA作为生物标志物的应用及大肠癌检测试剂盒 |
CN107746886B (zh) * | 2017-09-11 | 2019-10-01 | 朱伟 | 一种与结直肠癌辅助诊断相关的血浆miRNA标志物及其应用 |
WO2019144183A1 (en) * | 2018-01-23 | 2019-08-01 | La Trobe University | Biomarkers of colorectal cancer |
AU2019222462A1 (en) | 2018-02-14 | 2020-09-03 | Dermtech, Inc. | Novel gene classifiers and uses thereof in non-melanoma skin cancers |
CN110205367B (zh) * | 2018-02-28 | 2022-06-21 | 伽蓝(集团)股份有限公司 | 一种筛选保护皮肤细胞端粒的活性物的方法 |
JP7431812B2 (ja) * | 2018-05-09 | 2024-02-15 | ダームテック,インク. | 自己免疫疾患における新規な遺伝子分類とその使用 |
CN108753974B (zh) * | 2018-06-27 | 2022-05-06 | 深圳华大生命科学研究院 | 一种结直肠癌肿瘤标志物及其检测方法与装置 |
CN109557311B (zh) * | 2018-12-13 | 2022-02-15 | 中南大学湘雅医院 | 结直肠癌诊断标志物及结直肠癌的检测产品及其应用 |
KR102275465B1 (ko) * | 2019-01-18 | 2021-07-09 | 사회복지법인 삼성생명공익재단 | 전이성 대장암 치료물질 스크리닝 방법 |
WO2020182106A1 (en) * | 2019-03-11 | 2020-09-17 | The Chinese University Of Hong Kong | Mirna markers for colorectal cancer |
CN110438227A (zh) * | 2019-07-29 | 2019-11-12 | 广州中昱医学生物科技有限公司 | miR-17-92在结直肠癌诊断中的用途 |
CN112080568A (zh) * | 2020-09-27 | 2020-12-15 | 扬州大学 | 一种与湖羊肌肉细胞增殖相关的miRNA标志物及其检测引物和应用 |
WO2023032452A1 (ja) * | 2021-08-31 | 2023-03-09 | 国立大学法人大阪大学 | 2型糖尿病・大腸がんを検査する方法 |
WO2023036266A1 (en) * | 2021-09-08 | 2023-03-16 | Guangdong Jiyin Biotech Co. Ltd | Compositions and methods for diagnosing colorectal cancer |
CN113981096A (zh) * | 2021-11-30 | 2022-01-28 | 无锡市疾病预防控制中心 | 一种用于诊断结直肠癌的血浆miRNA标志物及其应用 |
WO2023222927A2 (en) | 2022-05-20 | 2023-11-23 | Novigenix Sa | Biomarkers for colorectal neoplasia |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
GB0415277D0 (en) * | 2004-07-07 | 2004-08-11 | Colonix Ltd | Apparatus and method for sampling mucosal surfaces |
US7939255B2 (en) | 2006-07-03 | 2011-05-10 | Catholic University Industry Academy Cooperation Foundation | Diagnostic methods for colorectal cancer |
WO2008055158A2 (en) * | 2006-10-30 | 2008-05-08 | University Of South Alabama | Microrna as biomarker in cancer |
JP5501766B2 (ja) | 2006-11-01 | 2014-05-28 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 肝細胞癌における生存および転移を予測するためのマイクロrna発現サイン |
KR20100093539A (ko) * | 2007-10-30 | 2010-08-25 | 베리덱스, 엘엘씨 | 대장암을 모니터링하는 방법 |
CN101424640B (zh) * | 2007-11-02 | 2012-07-25 | 江苏命码生物科技有限公司 | 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法 |
EP2268832A2 (en) * | 2008-03-06 | 2011-01-05 | Asuragen, INC. | Microrna markers for recurrence of colorectal cancer |
WO2009140670A2 (en) * | 2008-05-16 | 2009-11-19 | Veridex, Llc | Methods for assessing colorectal cancer and compositions for use therein |
WO2010004562A2 (en) | 2008-07-09 | 2010-01-14 | Rosetta Genomics Ltd. | Methods and compositions for detecting colorectal cancer |
CA2743211A1 (en) * | 2008-11-12 | 2010-05-20 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods and systems of using exosomes for determining phenotypes |
CN102439169B (zh) * | 2008-11-13 | 2014-11-19 | 复旦大学 | 用于结肠直肠癌的微rna表达谱分析的组合物和方法 |
WO2010126355A1 (en) * | 2009-04-29 | 2010-11-04 | Academisch Medisch Centrum Bij De Universiteit Van Amsterdam | Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure |
US20100317533A1 (en) | 2009-06-05 | 2010-12-16 | British Columbia Cancer Agency Branch | Biomarkers of cancer metastasis |
EP2336353A1 (en) * | 2009-12-17 | 2011-06-22 | febit holding GmbH | miRNA fingerprints in the diagnosis of diseases |
WO2011012136A1 (en) | 2009-07-28 | 2011-02-03 | Exiqon A/S | A method for classifying a human cell sample as cancerous |
CN101988060A (zh) * | 2009-07-30 | 2011-03-23 | 江苏命码生物科技有限公司 | 结直肠癌检测标记物及其检测方法、试剂盒和生物芯片 |
US8956817B2 (en) * | 2009-10-09 | 2015-02-17 | Baylor Research Institute | Identification of microRNAs (miRNAs) in fecal samples as biomarkers for gastroenterological cancers |
WO2011076142A1 (en) | 2009-12-24 | 2011-06-30 | Fudan University | Compositions and methods for microrna expession profiling in plasma of colorectal cancer |
WO2011076147A1 (en) | 2009-12-24 | 2011-06-30 | Fudan University | Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer |
EP2524059A4 (en) | 2010-01-13 | 2013-11-20 | Caris Life Sciences Luxembourg Holdings | DETECTION OF GASTROINTESTINAL DISEASES |
TW201207395A (en) * | 2010-06-23 | 2012-02-16 | Univ Hong Kong Chinese | Micro-RNA markers for colorectal cancer |
-
2009
- 2009-04-01 NO NO16160669A patent/NO3051026T3/no unknown
-
2012
- 2012-10-20 DK DK12852462.6T patent/DK2768986T3/en active
- 2012-10-20 HU HUE15158185A patent/HUE035614T2/en unknown
- 2012-10-20 CA CA2852850A patent/CA2852850C/en active Active
- 2012-10-20 KR KR1020157005756A patent/KR101912731B1/ko active IP Right Grant
- 2012-10-20 EP EP12852462.6A patent/EP2768986B1/en active Active
- 2012-10-20 PT PT12852462T patent/PT2768986T/pt unknown
- 2012-10-20 PT PT151581857T patent/PT2944700T/pt unknown
- 2012-10-20 RU RU2015108970A patent/RU2662975C1/ru active
- 2012-10-20 HU HUE12852462A patent/HUE039522T2/hu unknown
- 2012-10-20 RU RU2014120427A patent/RU2611189C2/ru active
- 2012-10-20 BR BR112014009643-0A patent/BR112014009643B1/pt active IP Right Grant
- 2012-10-20 US US13/656,690 patent/US20130102487A1/en not_active Abandoned
- 2012-10-20 BR BR122015004941-5A patent/BR122015004941B1/pt active IP Right Grant
- 2012-10-20 EP EP15158185.7A patent/EP2944700B1/en active Active
- 2012-10-20 KR KR1020147013663A patent/KR101900872B1/ko active IP Right Grant
- 2012-10-20 ES ES12852462.6T patent/ES2688693T3/es active Active
- 2012-10-20 PL PL12852462T patent/PL2768986T3/pl unknown
- 2012-10-20 ES ES15158185.7T patent/ES2662401T3/es active Active
- 2012-10-20 MX MX2015002910A patent/MX357119B/es unknown
- 2012-10-20 CN CN201280064096.7A patent/CN104145024A/zh active Pending
- 2012-10-20 AU AU2012356317A patent/AU2012356317B2/en active Active
- 2012-10-20 DK DK15158185.7T patent/DK2944700T3/en active
- 2012-10-20 CN CN201510098369.5A patent/CN104651521B/zh active Active
- 2012-10-20 MX MX2014004810A patent/MX357550B/es active IP Right Grant
- 2012-10-20 IN IN1855DEN2015 patent/IN2015DN01855A/en unknown
- 2012-10-20 PL PL15158185T patent/PL2944700T3/pl unknown
- 2012-10-20 US US14/352,462 patent/US20150087525A1/en not_active Abandoned
- 2012-10-20 JP JP2014536355A patent/JP6159727B2/ja active Active
- 2012-10-20 WO PCT/IB2012/003035 patent/WO2013093635A2/en active Application Filing
-
2015
- 2015-03-05 JP JP2015043433A patent/JP6203209B2/ja active Active
- 2015-03-05 US US14/639,539 patent/US20150176082A1/en not_active Abandoned
-
2016
- 2016-06-14 US US15/181,578 patent/US20160289771A1/en not_active Abandoned
-
2018
- 2018-06-28 US US16/022,597 patent/US20180346996A1/en active Pending
- 2018-08-08 US US16/058,940 patent/US20180355439A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014009643A2 (pt) | métodos para diagnosticar ou detectar neoplasia colorretal em um sujeito humano, biomarcador para progressão de doença e kits para um diagnóstico de neoplasia colorretal | |
IL254062B (en) | Kits containing ptk7 antibody and their use in the treatment, detection, diagnosis or monitoring of cancer | |
BR112013010952A2 (pt) | sistemas de rmn e métodos para a detecção rápida de analisados | |
WO2014028884A3 (en) | Cancer diagnostics using biomarkers | |
BR112013001752A2 (pt) | método de detectar doenças ou condições usando células fagocídicas | |
HK1214631A1 (zh) | 用於治療、診斷和監測阿爾茨海默病的方法 | |
BR112013020454A2 (pt) | método de diagnóstico de câncer e kit para diagnóstico usando medição de atividade de célula nk | |
ES2644277T3 (es) | Métodos de diagnóstico para determinar la prognosis del cáncer de pulmón de células no pequeñas | |
HK1199754A1 (en) | Method for monitoring, diagnosis and or prognosis of acute kidney injury in early stage | |
BR112013000745A2 (pt) | "método para diagnosticar ou detectar câncer colorretal em um individuo, método de tratamento e método para monitorar a eficacia de tratamento de câncer colorretal em um indivíduo" | |
BR112013022493A2 (pt) | equipamento e método para examinar, diagnosticar ou auxiliar no diagnóstico e no tratamento de problemas funcionais de visão | |
WO2013030578A3 (en) | Method for detecting nucleosomes | |
BRPI0906858A2 (pt) | Métodos para detecção de assinaturas de doença ou condições em fluidos corporais | |
BR112013012460A2 (pt) | "kit de diagnóstico para biomarcadores de benefício de saúde vaginal e método para a detecção de biomarcadoeres de benefício de saúde vaginal" | |
BR112012030587A2 (pt) | métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador | |
DE112013003442A5 (de) | Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointenstinaltrakt, insbesondere im Darm | |
HK1213522A1 (zh) | 用於診斷和治療炎性腸病的方法 | |
EP2726480A4 (en) | DETECTION OF ANALYTES USING FLUOROPHORES IN THE NEAR INFRARED | |
HK1216765A1 (zh) | 使用所測分析物改進疾病診斷的方法 | |
BR112013030886A2 (pt) | método, reagente e kit para medir hemoglobina glicada. | |
MX359328B (es) | Metodo para el diagnostico de enfermedad de niemann-pick. | |
BR112014007007A2 (pt) | método de diferenciação precoce, método de diagnóstico de fibrilação, uso de troponina cardíaca, dispositivo de diferenciação e dispositivo de diagnóstico | |
IL230693A0 (en) | Use of the i-3859 antibody for the detection and diagnosis of cancer | |
EP2825673A4 (en) | METHOD, KIT AND CHIP FOR BIOMARKER VALIDATION AND CLINICAL USE | |
AP2014007563A0 (en) | Biosensor for point-of-care diagnostic and on-sitemeasurements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/10/2012, OBSERVADAS AS CONDICOES LEGAIS. |